April 3, 2002
AmeriPath to Present at Banc of America Healthcare Conference

Riviera Beach, FL, April 3, 2002 – AmeriPath, Inc. (Nasdaq:PATH), one of the nation’s leading providers of anatomic pathology services, today announced it will participate in the Banc of America Securities Healthcare Conference 2002 to be held at the The Four Seasons Hotel in Las Vegas, Nevada. The AmeriPath presentation will be made by the Company’s Chairman and Chief Executive Officer, James C. New, and he’ll be accompanied by Executive Vice President of Genomic Strategies and Chief Medical Officer, Dennis M. Smith, Jr., M.D., on Thursday, April 4, 2002, at 11:35 a.m. PT.

The public is invited to listen to a webcast of the live presentation via the Internet and an archived replay until Friday, April 19, 2002. The webcast and replay will also be available on the AmeriPath website, http://www.ameripath.com/.

AmeriPath is a leading national provider of cancer diagnostics, genomics, and related information services. During 2001, AmeriPath diagnosed approximately 4.0 million tissue biopsies, and interpreted approximately 2.1 million Pap smears. The company’s extensive diagnostics infrastructure includes over 400 pathologists and doctorate-level scientists providing services in over 40 independent pathology laboratories, more than 200 hospitals, the Center for Advanced Diagnostics (CAD) and Dermpath Diagnostics, a division of AmeriPath. CAD provides specialized diagnostic testing and information services including Fluorescence In-Situ Hybridization (FISH), Flow Cytometry, DNA Analysis, Polymerase Chain Reaction (PCR), Molecular Genetics, Cytogenetics and HPV Typing. AmeriPath has over 60 board-certified dermatopathologists supporting Dermpath Diagnostics, one of the country’s leading providers of dermatopathology services in the growing skin diagnostic market. Additionally, AmeriPath provides clinical trial and research development support to firms involved in developing new cancer and genomic diagnostics and therapeutics.